No description available.

Hepatocyte growth factor (HGF) is a multifunctional protein, which secrets via Golgi complex after synthesized, and is hydrolyzed into an active heterodimer containing an £\ and a £] chain by extracellular protease. It is known that HGF functions through surface domain of Met, and thus induces mitosis and metastasis. The interaction domain of HGF is believed to be located in the £\-chain. In order to study these findings structurally and functionally, we designed and constructed four different recombinant coding regions of the gene (NK1, NK2, NK3, and NK4) which was then successfully expressed in E. coli. Purification of these four different recombinant proteins with glutathione-agarose column showed that all of the four constructs had been successfully expressed with some degradations. Cell proliferation assay showed that the recombinant proteins inhibited the growth of breast cancer cells to some extent. The assay also showed that GST-NK1 and GST-NK2 were better inhibitors than GST-NK3 and GST-NK4 to the cancer cells. It is concluded that E. coli expression is an appropriate system for achieving functional HGF.

Made available in DSpace on 2014-06-11T19:32:54Z (GMT). No. of bitstreams: 0 Previous issue date: 2006-09-15Bitstream added on 2014-06-13T18:44:29Z : No. of bitstreams: 1 abreu_il_dr_jabo.pdf: 406152 bytes, checksum: 68b3c6cb5d92e815f953857099241db8 (MD5) / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / Os países industrializados apresentam uma forte tendência em buscarem, cada vez mais, sistemas de controle biológico eficiente e específicos sendo menos tóxicos para os humanos e o ecossistema em geral. Os bioinseticidas à base de microrganismos entomopatogênicos não encontram grandes restrições quanto a sua utilização. Dentre as bactérias que possuem atividade entomopatogênica, Bacillus thuringiensis é a que apresenta maior valor potencial no controle dos insetos-praga, por apresentar vários genes cry e possuir mecanismos de recombinação genética como: conjugação e transformação. O objetivo desse estudo foi identificar e caracterizar a linhagem B. thuringiensis var. londrina. A análise morfológica dos cristais indica uma nova proteína Cry. Para comparação foram utilizadas as linhagens de B. thuringiensis var. tenebrionis, var. tolworthi e var. kurstaki - HD1 que possuem os genes cry3Aa, cry3Ba e cry1Aa, respectivamente. Foi realizada a extração do DNA total das quatro linhagens, em seguida esse material foi submetido à reação de PCR com os oligonucleotideos iniciadores específicos dos genes acima citado. Para a confirmação dos resultados utilizou-se a técnica de hibridização por Southern blotting e seqüenciamento dos amplicon. O amplicom para o gene cry3 obtido pela linhagem padrão B. thuringiensis var. tenebrionis foi igual ao tamanho esperado, porém o obtido pela linhagem var. londrina foi maior em números de nucleotídeo que o esperado, indicando uma possível recombinação. A técnica de Southern blotting confirmou a recombinação do gene mostrando diferenças entre as bandas das linhagens padrão e da linhagem var. londrina, confirmando assim um novo gene cry3. Os bioensaios executados com esse novo gene não indicaram eficiência para alguns insetos-praga de lavoura da ordem Lepidoptera e foram eficientes... / Industrialized countries show a strong tendency to look for efficient and specific biological control systems that are less toxic to humans and ecosystems. Bioinsecticides based on entomopathogenic microorganisms are well accepted by the public. Among those, bacteria that exhibit such entomopathogenic activities, Bacillus thuringiensis is the one with major potential over the pests, since it harbors several cry genes and holds genetic recombination mechanisms such as bacterial conjugation and transformation in order to accomplish these control procedures. The aim of this research was to identify and characterize the strain of B. thuringiensis var. londrina. As a comparison some other strains of B. thuringiensis such as B. thuringiensis var. tenebrionis, var. tolworthi and var. kurstaki - HD1 that holds the genes cry3Aa, cry3Ba and cry1Aa, were used respectively. Alkaline lysis procedure was used for the DNA extraction from the four bacterial strains followed by its use on PCR reactions using the specific primers for the genes. To confirm the results were utilized the techniques of Southern blotting hybridization and DNA sequencing. The obtained amplicons have shown a difference in size considering the pattern strains compared to the var. londrina. The genetic recombination that took place so as to generate the var. londrina cry gene was detected by Southern blotting analysis, the hybridization results confirm the genetic recombination showing the banding pattern differences that took place generating the new cry3 gene. The bioassays showed that the recombinant gene was efficient to control Sphenophorus levis (Coleopteran).

Orientador: Manoel Victor Franco Lemos / Banca: José Eduardo Garcia / Banca: Cristina Lacerda Soares Petrarolha Silva / Banca: Odair Aparecido Fernandes / Banca: Antônio Carlos Monteiro / Resumo: Os países industrializados apresentam uma forte tendência em buscarem, cada vez mais, sistemas de controle biológico eficiente e específicos sendo menos tóxicos para os humanos e o ecossistema em geral. Os bioinseticidas à base de microrganismos entomopatogênicos não encontram grandes restrições quanto a sua utilização. Dentre as bactérias que possuem atividade entomopatogênica, Bacillus thuringiensis é a que apresenta maior valor potencial no controle dos insetos-praga, por apresentar vários genes cry e possuir mecanismos de recombinação genética como: conjugação e transformação. O objetivo desse estudo foi identificar e caracterizar a linhagem B. thuringiensis var. londrina. A análise morfológica dos cristais indica uma nova proteína Cry. Para comparação foram utilizadas as linhagens de B. thuringiensis var. tenebrionis, var. tolworthi e var. kurstaki - HD1 que possuem os genes cry3Aa, cry3Ba e cry1Aa, respectivamente. Foi realizada a extração do DNA total das quatro linhagens, em seguida esse material foi submetido à reação de PCR com os oligonucleotideos iniciadores específicos dos genes acima citado. Para a confirmação dos resultados utilizou-se a técnica de hibridização por Southern blotting e seqüenciamento dos amplicon. O amplicom para o gene cry3 obtido pela linhagem padrão B. thuringiensis var. tenebrionis foi igual ao tamanho esperado, porém o obtido pela linhagem var. londrina foi maior em números de nucleotídeo que o esperado, indicando uma possível recombinação. A técnica de Southern blotting confirmou a recombinação do gene mostrando diferenças entre as bandas das linhagens padrão e da linhagem var. londrina, confirmando assim um novo gene cry3. Os bioensaios executados com esse novo gene não indicaram eficiência para alguns insetos-praga de lavoura da ordem Lepidoptera e foram eficientes... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Industrialized countries show a strong tendency to look for efficient and specific biological control systems that are less toxic to humans and ecosystems. Bioinsecticides based on entomopathogenic microorganisms are well accepted by the public. Among those, bacteria that exhibit such entomopathogenic activities, Bacillus thuringiensis is the one with major potential over the pests, since it harbors several cry genes and holds genetic recombination mechanisms such as bacterial conjugation and transformation in order to accomplish these control procedures. The aim of this research was to identify and characterize the strain of B. thuringiensis var. londrina. As a comparison some other strains of B. thuringiensis such as B. thuringiensis var. tenebrionis, var. tolworthi and var. kurstaki - HD1 that holds the genes cry3Aa, cry3Ba and cry1Aa, were used respectively. Alkaline lysis procedure was used for the DNA extraction from the four bacterial strains followed by its use on PCR reactions using the specific primers for the genes. To confirm the results were utilized the techniques of Southern blotting hybridization and DNA sequencing. The obtained amplicons have shown a difference in size considering the pattern strains compared to the var. londrina. The genetic recombination that took place so as to generate the var. londrina cry gene was detected by Southern blotting analysis, the hybridization results confirm the genetic recombination showing the banding pattern differences that took place generating the new cry3 gene. The bioassays showed that the recombinant gene was efficient to control Sphenophorus levis (Coleopteran). / Doutor

Mucopolysaccharidosis (MPS) IIIB is an autosomal recessive disorder caused by a defect in alpha-N-acetylglucosaminidase (NAGLU), a lysosomal enzyme involved in the degradation of heparan sulphate. Dysfunctional NAGLU gives rise to a clinical phenotype of severe and progressive mental retardation, often accompanied by hyperactivity and aggressive behaviour. At present, there is no effective treatment for MPS IIIB. However, cloning of the human NAGLU cDNA has made the potential production of human recombinant enzyme for use in enzyme replacement therapy (ERT) a viable option. The work outlined herein focuses on attempts to produce human recombinant NAGLU (rNAGLU) using both yeast and insect cell based expression systems; with the major focus on yeast based expression. Use of a humanized yeast strain, codon optimisation of a portion of the NAGLU gene, selection of Mut+, MutS and multiple integrant strains, and growth at decreased temperature were explored to optimise NAGLU expression in the methylotrophic yeast, Pichia pastoris. As none of these measures resulted in abundant NAGLU production, Sf9 and Tni insect cell lines were investigated as an alternate expression system. Additionally, a protein transduction domain (PTD) was fused to NAGLU (NTAT) to circumvent current problems faced in delivering therapeutic enzymes to the brain. NAGLU protein, with and without a fused PTD, were expressed using stable transfection and baculovirus infection techniques. Small scale experiments utilizing the baculovirus expression vector system (BEVS) have yielded promising results, generating functionally active NAGLU and NTAT protein of the expected approximately 80-85 kDa molecular mass. This preliminary success indicates the BEVS may be an attractive option for the large scale production of rNAGLU and rNTAT.

Mucopolysaccharidosis (MPS) IIIB is an autosomal recessive disorder caused by a defect in alpha-N-acetylglucosaminidase (NAGLU), a lysosomal enzyme involved in the degradation of heparan sulphate. Dysfunctional NAGLU gives rise to a clinical phenotype of severe and progressive mental retardation, often accompanied by hyperactivity and aggressive behaviour. At present, there is no effective treatment for MPS IIIB. However, cloning of the human NAGLU cDNA has made the potential production of human recombinant enzyme for use in enzyme replacement therapy (ERT) a viable option. The work outlined herein focuses on attempts to produce human recombinant NAGLU (rNAGLU) using both yeast and insect cell based expression systems; with the major focus on yeast based expression. Use of a humanized yeast strain, codon optimisation of a portion of the NAGLU gene, selection of Mut+, MutS and multiple integrant strains, and growth at decreased temperature were explored to optimise NAGLU expression in the methylotrophic yeast, Pichia pastoris. As none of these measures resulted in abundant NAGLU production, Sf9 and Tni insect cell lines were investigated as an alternate expression system. Additionally, a protein transduction domain (PTD) was fused to NAGLU (NTAT) to circumvent current problems faced in delivering therapeutic enzymes to the brain. NAGLU protein, with and without a fused PTD, were expressed using stable transfection and baculovirus infection techniques. Small scale experiments utilizing the baculovirus expression vector system (BEVS) have yielded promising results, generating functionally active NAGLU and NTAT protein of the expected approximately 80-85 kDa molecular mass. This preliminary success indicates the BEVS may be an attractive option for the large scale production of rNAGLU and rNTAT.